Valentina Belli
Valentina Belli
Universitą degli Studi della Campania "Luigi Vanvitelli"
Verified email at unina.it
TitleCited byYear
Transport across the cell-membrane dictates nanoparticle fate and toxicity: a new paradigm in nanotoxicology
D Guarnieri, S Sabella, O Muscetti, V Belli, MA Malvindi, S Fusco, ...
Nanoscale 6 (17), 10264-10273, 2014
532014
Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity
D Guarnieri, MA Malvindi, V Belli, PP Pompa, P Netti
Journal of nanoparticle research 16 (2), 2229, 2014
342014
Sub-100 nm biodegradable nanoparticles: in vitro release features and toxicity testing in 2D and 3D cell cultures
M Biondi, D Guarnieri, H Yu, V Belli, PA Netti
Nanotechnology 24 (4), 045101, 2013
252013
Multilayered silica-biopolymer nanocapsules with a hydrophobic core and a hydrophilic tunable shell thickness
R Vecchione, G Luciani, V Calcagno, A Jakhmola, B Silvestri, D Guarnieri, ...
Nanoscale 8 (16), 8798-8809, 2016
192016
Tumor‐activated prodrug (TAP)‐conjugated nanoparticles with cleavable domains for safe doxorubicin delivery
D Guarnieri, M Biondi, H Yu, V Belli, AP Falanga, M Cantisani, S Galdiero, ...
Biotechnology and bioengineering 112 (3), 601-611, 2015
182015
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
MF Della Corte CM, Malapelle U, Vigliar E, Pepe F, Troncone G, Ciaramella V ...
Oncotarget. 2017 Apr 4;8(14):23020-23032. doi: 10.18632/oncotarget.15479., 2017
13*2017
Biocompatible nanoparticles sensing the matrix metallo-proteinase 2 for the on-demand release of anticancer drugs in 3D tumor spheroids
M Cantisani, D Guarnieri, M Biondi, V Belli, M Profeta, L Raiola, PA Netti
Colloids and Surfaces B: Biointerfaces 135, 707-716, 2015
122015
Bioinspired oil core/silica shell nanocarriers with tunable and multimodal functionalities
A Jakhmola, R Vecchione, D Guarnieri, V Belli, D Calabria, PA Netti
Advanced healthcare materials 4 (17), 2688-2698, 2015
112015
Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity
D Guarnieri, O Muscetti, A Falanga, S Fusco, V Belli, E Perillo, E Battista, ...
Nanotechnology 26 (41), 415101, 2015
102015
Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells
F Morgillo, CM Della Corte, A Diana, C di Mauro, V Ciaramella, G Barra, ...
Oncotarget 8 (44), 76479, 2017
92017
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
DOI: 10.18632/oncotarget.20054, 2017
8*2017
Dynamics of nanoparticle diffusion and uptake in three-dimensional cell cultures
V Belli, D Guarnieri, M Biondi, F della Sala, PA Netti
Colloids and Surfaces B: Biointerfaces 149, 7-15, 2017
82017
Biostability enhancement of oil core—polysaccharide multilayer shell via photoinitiator free thiol-ene ‘click’reaction
V Calcagno, R Vecchione, A Sagliano, A Carella, D Guarnieri, V Belli, ...
Colloids and Surfaces B: Biointerfaces 142, 281-289, 2016
82016
Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation
S Napolitano, G Martini, E Martinelli, V Belli, A Parascandolo, ...
Oncotarget 8 (40), 67592, 2017
52017
Metabolomic approach for a rapid identification of natural products with cytotoxic activity against human colorectal cancer cells
V Graziani, M Scognamiglio, V Belli, A Esposito, B D’Abrosca, ...
Scientific reports 8 (1), 5309, 2018
42018
Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
PP Vitiello, C Cardone, G Martini, D Ciardiello, V Belli, N Matrone, G Barra, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 41, 2019
32019
A functional connection between dyskerin and energy metabolism
A Angrisani, N Matrone, V Belli, R Vicidomini, N Di Maio, M Turano, ...
Redox biology 14, 557-565, 2018
32018
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models
V Belli, N Matrone, S Napolitano, G Migliardi, F Cottino, A Bertotti, ...
Journal of Experimental & Clinical Cancer Research 38 (1), 236, 2019
12019
Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal …
S Napolitano, G Martini, E Martinelli, CM Della Corte, F Morgillo, V Belli, ...
Oncotarget 8 (47), 82773, 2017
12017
A new role for human dyskerin in vesicular trafficking
N Di Maio, R Vicidomini, A Angrisani, V Belli, M Furia, M Turano
FEBS open bio 7 (10), 1453-1468, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20